"A wave of epigenetic therapies is offering hope as ways to cure chronic hepatitis B — a lingering liver infection that is caused by the hepatitis B virus (HBV) and affects more than 250 million people around the world."
https://www.nature.com/articles/d41586-026-02981-9?utm_source=Live+Audience&utm_campaign=19641a4507-nature-briefing-daily-20260922&utm_medium=email&utm_term=0_-33f35e09ea-50276768
No comments:
Post a Comment